Human Creatine Kinase MB Isoenzyme (CKMB) ELISA kit

Specifications

Product Data
Description	Human Creatine Kinase MB Isoenzyme (CKMB) ELISA kit
Size	1 x 96 wells
Format	8x12 divisible strips
Assay Type	Solid Phase Sandwich ELISA
Assay Length	3 hours
Signal	Colorimetric
Sample Type	Serum
Specificity	This kit is used for quantitative detection human Creatine Kinase MB Isoenzyme (CKMB)
Reactivity	Human
Cross Reactivity	There is no detectable cross-reactivity with other relevant proteins.
Interference	No significant interference observed with available related molecules.
Components	1. Antibody-Coated Microtiter Plate: 12x8x1 2. Liquid CK-MB Standards containing:0,7.5,15,50,100, & 200 ng/ml CK-MB. 1.0 ml for each standard dose. Store at -20?: 1ml 3. Enzyme Conjugate Reagent, (Ready to Use): 22 ml 4. TMB Reagent (one-step): 11ml 5. Stop Solution: 11ml 6. Wash Concentrate 20x: 1 Bottle: 25 ml
Background	Creatine Kinase (CK-MB) is the enzyme being used as the definitive serum marker for the diagnosis or exclusion of acute myocardial infarction (AMI).The determination of CK-MB mass has proven to be more specific for myocardial necrosis than the long-standing CK-MB activity and CK-MB inhibition assays. CK- MB, released after AMI, is detectable in blood as early as 3-4 hours after the onset of symptoms, and remains elevated for approximately 65 hours post infarct 8-9. CK-MB mass levels are reportedly 50% diagnostic for AMI after 3 hours and > 90% diagnostic at 6 hours 10. Such accuracy makes CK-MB mass determinations useful in confirming AMI in patients presenting to the ER with non-diagnostic ECGs > 6 hours after the onset of symptoms.
Gene Symbol	CKM

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.